- Home
- Investor Relations
- Financial Outline
Consolidated balance sheet
Assets
Current assets
(Million yen)
|
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
Cash and deposits |
12,751 |
15,478 |
15,739 |
16,581 |
16,922 |
Notes and accounts receivable-trade |
5,330 |
4,026 |
3,199 |
- |
- |
Notes, accounts receivable-trade and contract assets |
- |
- |
- |
3,395 |
4,966 |
Electronically recorded monetary claims – operating |
2,078 |
1,568 |
938 |
1,672 |
2,108 |
Securities |
- |
- |
500 |
0 |
500 |
Merchandise and finished goods |
4,244 |
3,713 |
3,852 |
3,670 |
7,957 |
Work in process |
42 |
30 |
28 |
93 |
89 |
Raw materials and supplies |
871 |
542 |
265 |
669 |
482 |
Other |
1,079 |
889 |
905 |
683 |
884 |
Allowance for doubtful accounts |
-2 |
-1 |
-2 |
-3 |
-284 |
Total current assets |
26,397 |
26,247 |
25,427 |
26,764 |
33,626 |
Non-current assets
Property, plant and equipment
Buildings and structures |
3,929 |
3,824 |
3,601 |
3,378 |
3,205 |
Machinery, equipment and vehicles |
49 |
63 |
43 |
31 |
43 |
Tools, furniture and fixtures |
1,261 |
884 |
683 |
625 |
592 |
Land |
4,162 |
4,162 |
4,162 |
4,162 |
4,162 |
Construction in progress |
233 |
132 |
181 |
161 |
221 |
Total property, plant and equipment |
9,636 |
9,067 |
8,672 |
8,359 |
8,224 |
Intangible assets
Software |
3,814 |
3,525 |
2,982 |
2,318 |
2,044 |
Goodwill |
- |
- |
- |
- |
812 |
Other |
33 |
34 |
34 |
33 |
33 |
Total intangible assets |
3,848 |
3,560 |
3,016 |
2,351 |
2,889 |
Investments and other assets
Investment securities |
328 |
262 |
764 |
795 |
286 |
Deferred tax assets |
1,169 |
1,133 |
743 |
679 |
615 |
Investment property |
919 |
901 |
890 |
881 |
865 |
Membership |
278 |
0 |
251 |
251 |
229 |
Lease and guarantee deposits |
470 |
479 |
438 |
429 |
451 |
Other |
840 |
946 |
1,031 |
1,132 |
1,315 |
Allowance for doubtful accounts |
-159 |
-147 |
-150 |
-154 |
-205 |
Total investments and other assets |
3,847 |
3,827 |
3,968 |
4,014 |
3,557 |
Total non-current assets |
17,331 |
16,455 |
15,657 |
14,725 |
14,672 |
Total assets |
43,729 |
42,702 |
41,084 |
41,489 |
48,298 |
Liabilities
Current liabilities
(Million yen)
|
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
Notes and accounts payable-trade |
2,860 |
2,200 |
1,881 |
2,594 |
4,193 |
Short-term borrowings |
3,000 |
3,000 |
3,000 |
2,000 |
2,000 |
Current portion of long-term loans payable |
0 |
300 |
0 |
0 |
0 |
Accounts payable-other |
1,391 |
1,178 |
862 |
857 |
1,433 |
Accrued expenses |
819 |
760 |
737 |
757 |
844 |
Income taxes payable |
245 |
406 |
26 |
32 |
1,203 |
Advances received |
399 |
373 |
318 |
- |
- |
Contract liabilities |
- |
- |
- |
120 |
90 |
Provision for product warranties |
12 |
40 |
23 |
61 |
40 |
Provision for bonuses for directors (and other officers) |
60 |
62 |
49 |
64 |
75 |
Provision for shareholder benefit program |
38 |
42 |
- |
- |
- |
Other |
420 |
509 |
256 |
341 |
320 |
Total current liabilities |
12,339 |
11,148 |
9,519 |
9,419 |
13,966 |
Non-current liabilities
Provision for retirement benefits for directors (and other officers) |
357 |
376 |
404 |
433 |
453 |
Other |
312 |
272 |
274 |
266 |
246 |
Total non-current liabilities |
1,491 |
1,147 |
903 |
928 |
932 |
Total liabilities |
13,831 |
12,296 |
10,422 |
10,348 |
14,898 |
Net assets
(Million yen)
|
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
Share capital |
674 |
674 |
674 |
674 |
674 |
Capital surplus |
680 |
680 |
680 |
680 |
680 |
Retained earnings |
28,688 |
29,158 |
29,180 |
29,662 |
31,924 |
Treasury stock |
-1 |
-1 |
-1 |
-1 |
-1 |
Total shareholders’ equity |
30,041 |
30,511 |
30,532 |
31,014 |
33,276 |
Valuation difference on
available-for-sale securities |
31 |
14 |
15 |
12 |
16 |
Remeasurements of defined
benefit plans |
-174 |
-119 |
114 |
114 |
106 |
Total accumulated other
comprehensive income |
-143 |
-105 |
129 |
127 |
123 |
Total net assets |
29,898 |
30,406 |
30,662 |
31,141 |
33,399 |
Total liabilities and net assets |
43,729 |
42,702 |
41,084 |
41,489 |
48,298 |
Consolidated statement of income
(Million yen)
|
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
Net sales |
31,251 |
33,068 |
23,345 |
24,390 |
31,824 |
Cost of sales |
19,492 |
20,881 |
13,840 |
14,246 |
17,316 |
Gross profit |
11,758 |
12,186 |
9,504 |
10,143 |
14,507 |
Selling, general and administrative expenses |
10,145 |
10,608 |
8,897 |
8,952 |
10,487 |
Operating profit |
1,613 |
1,577 |
607 |
1,191 |
4,019 |
Non-operating income |
193 |
154 |
440 |
235 |
300 |
Non-operating expenses |
58 |
57 |
60 |
59 |
59 |
Ordinary profit |
1,748 |
1,674 |
986 |
1,367 |
4,260 |
Extraordinary income |
0 |
1 |
1 |
0 |
6 |
Extraordinary losses |
66 |
105 |
10 |
70 |
128 |
Profit before income taxes |
1,682 |
1,570 |
977 |
1,296 |
4,137 |
Income taxes-current |
261 |
490 |
77 |
32 |
1,145 |
Income taxes-deferred |
157 |
18 |
287 |
35 |
64 |
Total income taxes |
419 |
508 |
364 |
67 |
1,210 |
Profit (loss) attributable to owners of parent |
1,263 |
1,061 |
612 |
1,228 |
2,927 |
Consolidated statements of cash flows
(Million yen)
|
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
Cash flows from operating activities |
1,875 |
5,006 |
3,396 |
3,220 |
2,983 |
Cash flows from investing activities |
-2,364 |
-1,688 |
-2,242 |
-564 |
-1,976 |
Cash flows from financing activities |
-592 |
-591 |
-891 |
-1,814 |
-666 |
Net increase (decrease in parenthesis) in cash and cash equivalents |
-1,080 |
2,726 |
261 |
841 |
341 |
Cash and cash equivalents at beginning of period |
13,832 |
12,751 |
15,478 |
15,739 |
16,581 |
Cash and cash equivalents at end of period |
12,751 |
15,478 |
15,739 |
16,581 |
16,922 |